EHA Library - The official digital education library of European Hematology Association (EHA)

This abstract is embargoed until Friday, June 14, 2024 (09:00 CEST).

Presentation during EHA2024: All Oral presentations will be presented between Friday, June 14, 2024 and Sunday, June 16, 2024 and will be accessible for on-demand viewing from Wednesday, June 19 until Thursday, August 15, 2024 on the Congress platform.

Abstract: S318

Title: A PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF CHILDREN WITH CHRONIC IMMUNE THROMBOCYTOPENIA (AVA-PED-301)


Abstract Type: Oral Presentation

Keywords: Clinical trial | Phase III | Pediatric | Immune thrombocytopenia (ITP)
This abstract is embargoed until Friday, June 14, 2024 (09:00 CEST).

Presentation during EHA2024: All Oral presentations will be presented between Friday, June 14, 2024 and Sunday, June 16, 2024 and will be accessible for on-demand viewing from Wednesday, June 19 until Thursday, August 15, 2024 on the Congress platform.

Abstract: S318

Title: A PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF CHILDREN WITH CHRONIC IMMUNE THROMBOCYTOPENIA (AVA-PED-301)


Abstract Type: Oral Presentation

Keywords: Clinical trial | Phase III | Pediatric | Immune thrombocytopenia (ITP)
A PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF CHILDREN WITH CHRONIC IMMUNE THROMBOCYTOPENIA (AVA-PED-301)
Rachael F. Grace
Rachael F. Grace
Author(s): Rachael F. Grace,  
Rachael F. Grace
Affiliations:
Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Division of Hematology/Oncology, Boston, United States of America
Göksel Leblebisatan,  
Göksel Leblebisatan
Affiliations:
Çukurova University Medical Faculty, Department of Pediatric Hematology, Adana, Turkey
Yesim Aydinok,  
Yesim Aydinok
Affiliations:
Ege University School of Medicine, Department of Pediatric Hematology and Oncology, Izmir, Turkey
Şule Ünal Cangül,  
Şule Ünal Cangül
Affiliations:
Hacettepe University Faculty of Medicine, Department of Pediatric Hematology, Ankara, Turkey
John John Grainger,  
John John Grainger
Affiliations:
Royal Manchester Children's Hospital, Department of Haematology, Manchester, United Kingdom
Jessica Zhang,  
Jessica Zhang
Affiliations:
Sobi Inc, Durham, United States of America
Linda Smallwood,  
Linda Smallwood
Affiliations:
Sobi Inc, Durham, United States of America
Emily de León,  
Emily de León
Affiliations:
Sobi Inc, Durham, United States of America
Brian Jamieson
Brian Jamieson
Affiliations:
Sobi Inc, Durham, United States of America
(Abstract release date: 05/14/24) EHA Library. Grace R. 06/13/2024; 422422; S318
This abstract is embargoed until Friday, June 14, 2024 (09:00 CEST).

Presentation during EHA2024: All Oral presentations will be presented between Friday, June 14, 2024 and Sunday, June 16, 2024 and will be accessible for on-demand viewing from Wednesday, June 19 until Thursday, August 15, 2024 on the Congress platform.

Abstract: S318

Title: A PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF CHILDREN WITH CHRONIC IMMUNE THROMBOCYTOPENIA (AVA-PED-301)


Abstract Type: Oral Presentation

Keywords: Clinical trial | Phase III | Pediatric | Immune thrombocytopenia (ITP)
This abstract is embargoed until Friday, June 14, 2024 (09:00 CEST).

Presentation during EHA2024: All Oral presentations will be presented between Friday, June 14, 2024 and Sunday, June 16, 2024 and will be accessible for on-demand viewing from Wednesday, June 19 until Thursday, August 15, 2024 on the Congress platform.

Abstract: S318

Title: A PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF CHILDREN WITH CHRONIC IMMUNE THROMBOCYTOPENIA (AVA-PED-301)


Abstract Type: Oral Presentation

Keywords: Clinical trial | Phase III | Pediatric | Immune thrombocytopenia (ITP)

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies